IQIRVO Ipsen Pty Ltd
Product name
IQIRVO
Sponsor
Accepted date
Apr-2024
Active ingredients
elafibranor
Proposed indication
For the treatment of primary biliary cholangitis (PBC)
Application type
A (new medicine)
Publication date
Apr-2024